Major Depressive Disorder

Supernus’ SPN-820 Shows Rapid Symptom Improvement in Major Depressive Disorder

6 months ago talkbio0Tagged Clinical Trials, Major Depressive Disorder, MDD, Mental Depression, Rapid-Acting, SPN-820, Supernus Pharmaceuticals, Unipolar Depression

Supernus Pharmaceuticals, SPN-820, Major Depressive Disorder (MDD), Rapid-Acting Depression Treatment, Clinical Trial Results

Johnson & Johnson’s Seltorexant Achieves Significant Improvement in Depressive Symptoms and Sleep Disturbance in Phase 3 Trial

11 months ago talkbio0Tagged Johnson and Johnson, Major Depressive Disorder, Mental Depression, Neuroscience discipline, Phase 3 trial, Seltorexant, Sleeplessness, Symptoms aspect

Johnson & Johnson, Seltorexant, Major Depressive Disorder, Insomnia Symptoms, Phase 3 Trial, Neuroscience, Depression Treatment

Intra-Cellular’s Caplyta Shows Promising Results in Major Depressive Disorder Study

1 year ago talkbio0Tagged adjunctive therapy, blockbuster label, Caplyta, Clinical Global Impression Original Version Questionnaire, expansion, Intra-Cellular Therapies, Lumateperone, Major Depressive Disorder, MDD, Montgomery-Åsberg depression rating scale, Montgomery-Asberg Depression Rating Scale Questionnaire, Positive Clinical Trial, Study 501, Unipolar Depression

Intra-Cellular Therapies, Caplyta (lumateperone), Major Depressive Disorder (MDD), Positive clinical trial results, Study 501, Montgomery-Åsberg Depression Rating Scale (MADRS), Clinical Global Impression Scale, Adjunctive therapy, Potential blockbuster label expansion